Hongyan Chen
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Gut microbiota and health
- RNA modifications and cancer
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 15
- Cancer-related gene regulation 15
- Epigenetics and DNA Methylation 10
- Circular RNAs in diseases 6
- S100 Proteins and Annexins 6
- Extracellular vesicles in disease 6
-
- Cancer-related molecular mechanisms research 11
- MicroRNA in disease regulation 10
- Co-authors
- Zhihua Liu (28 shared papers)Norman R. Pace (2 shared papers)Tianyi Zhang (2 shared papers)Noam Harpaz (1 shared paper)R. Balfour Sartor (1 shared paper)Christina M. Hamm (2 shared papers)Charles E. Robertson (2 shared papers)Wei Zhu (3 shared papers)
- Journals
- Cancer Letters (4 papers)Nature Communications (3 papers)Journal of Biological Chemistry (3 papers)Nucleic Acids Research (3 papers)Oncogene (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hongyan Chen
76 papers receiving 2.7k citations
Hongyan Chen's Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 623
- Molecular Biology 1.8k
- Immunology 524
- Oncology 568
- Gastroenterology 114
Countries citing papers authored by Hongyan Chen
This map shows the geographic impact of Hongyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongyan Chen more than expected).
Fields of papers citing papers by Hongyan Chen
This network shows the impact of papers produced by Hongyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongyan Chen. The network helps show where Hongyan Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongyan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 465 | |
| 2 | Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer Hit paper breakdown → | 2021 | 434 |
| 3 | 2021 | 142 | |
| 4 | 2019 | 108 | |
| 5 | 2011 | 101 | |
| 6 | 2014 | 100 | |
| 7 | 2008 | 81 | |
| 8 | 2017 | 64 | |
| 9 | 2007 | 62 | |
| 10 | 2021 | 59 | |
| 11 | 2019 | 55 | |
| 12 | 2013 | 51 | |
| 13 | 2021 | 51 | |
| 14 | 2017 | 50 | |
| 15 | 2012 | 46 | |
| 16 | 2020 | 45 | |
| 17 | 2015 | 45 | |
| 18 | 2018 | 43 | |
| 19 | 2018 | 39 | |
| 20 | 2018 | 39 |
About Hongyan Chen
Hongyan Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Genetics and Immunology, having authored 79 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), Cancer-related gene regulation (15 papers), Cancer-related molecular mechanisms research (11 papers), Epigenetics and DNA Methylation (10 papers), MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (6 papers), S100 Proteins and Annexins (6 papers) and Extracellular vesicles in disease (6 papers). The work is most often cited by research in Cancer Research (623 citations), Molecular Biology (1.8k citations), Immunology (524 citations), Oncology (568 citations) and Gastroenterology (114 citations). Hongyan Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhihua Liu, Norman R. Pace, Tianyi Zhang, Noam Harpaz, R. Balfour Sartor, Christina M. Hamm, Charles E. Robertson, Wei Zhu, Edgar C. Boedeker and Daniel N. Frank. Their work appears in journals such as Cancer Letters, Nature Communications, Journal of Biological Chemistry, Nucleic Acids Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.